Is Quad healing blend legal in the United Kingdom?

The same four peptides as KLOW at a completely different ratio, typically 5 mg TB-500, 5 mg BPC-157, 10 mg KPV and 5 mg GHK-Cu in a 25 mg vial. Copper peptide is 20% of the powder here against 62.5% in KLOW, which is roughly 0.8 mg of elemental copper per vial instead of 7.9 mg. No study has tested any four-peptide combination in any species.

This vial matters because of what it proves about the category. KLOW and this product contain the same four ingredients.

Mechanism: Four assumed-additive mechanisms in one solution. GHK-Cu carries copper into tissue and drives collagen and glycosaminoglycan production in culture and in rodent wound chambers.

Regulatory history: Not approved. No four-peptide blend of this kind has been evaluated by any regulator.

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Quad healing blend at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.